What Happened?
Princeton, NJ-based PMV-Pharmaceutcals Promoted Michael Carulli as Chief Financial Officer
About the Company
PMV is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
About the Person
Michael Carulli is Chief Financial Officer at PMV Pharmaceutcals. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile